Literature DB >> 25150047

Altered calcium signaling in cancer cells.

Teneale A Stewart1, Kunsala T D S Yapa1, Gregory R Monteith2.   

Abstract

It is the nature of the calcium signal, as determined by the coordinated activity of a suite of calcium channels, pumps, exchangers and binding proteins that ultimately guides a cell's fate. Deregulation of the calcium signal is often deleterious and has been linked to each of the 'cancer hallmarks'. Despite this, we do not yet have a full understanding of the remodeling of the calcium signal associated with cancer. Such an understanding could aid in guiding the development of therapies specifically targeting altered calcium signaling in cancer cells during tumorigenic progression. Findings from some of the studies that have assessed the remodeling of the calcium signal associated with tumorigenesis and/or processes important in invasion and metastasis are presented in this review. The potential of new methodologies is also discussed. This article is part of a Special Issue entitled: Membrane channels and transporters in cancers.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Calcium channels; Calcium pumps; Calcium remodeling; Calcium signaling; Cancer; Cytosolic free Ca(2+)

Mesh:

Substances:

Year:  2014        PMID: 25150047     DOI: 10.1016/j.bbamem.2014.08.016

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  100 in total

1.  Triple-negative breast cancer cell line sensitivity to englerin A identifies a new, targetable subtype.

Authors:  Corena V Grant; Chase M Carver; Shayne D Hastings; Karthik Ramachandran; Madesh Muniswamy; April L Risinger; John A Beutler; Susan L Mooberry
Journal:  Breast Cancer Res Treat       Date:  2019-06-22       Impact factor: 4.872

Review 2.  Crosstalk between calcium and reactive oxygen species signaling in cancer.

Authors:  Nadine Hempel; Mohamed Trebak
Journal:  Cell Calcium       Date:  2017-01-18       Impact factor: 6.817

Review 3.  SERCA control of cell death and survival.

Authors:  Elie R Chemaly; Luca Troncone; Djamel Lebeche
Journal:  Cell Calcium       Date:  2017-07-12       Impact factor: 6.817

4.  Genetic variants in the calcium signaling pathway genes are associated with cutaneous melanoma-specific survival.

Authors:  Xiaomeng Wang; Hongliang Liu; Yinghui Xu; Jichun Xie; Dakai Zhu; Christopher I Amos; Shenying Fang; Jeffrey E Lee; Xin Li; Hongmei Nan; Yanqiu Song; Qingyi Wei
Journal:  Carcinogenesis       Date:  2019-04-29       Impact factor: 4.944

Review 5.  TMBIM-mediated Ca2+ homeostasis and cell death.

Authors:  Qun Liu
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-01-05       Impact factor: 4.739

6.  Intracellular calcium oscillations in strongly metastatic human breast and prostate cancer cells: control by voltage-gated sodium channel activity.

Authors:  Nahit Rizaner; Rustem Onkal; Scott P Fraser; Alessandro Pristerá; Kenji Okuse; Mustafa B A Djamgoz
Journal:  Eur Biophys J       Date:  2016-09-24       Impact factor: 1.733

7.  Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.

Authors:  Hao Li; Jing-Wei Liu; Shuang Liu; Yuan Yuan; Li-Ping Sun
Journal:  Dig Dis Sci       Date:  2017-09-15       Impact factor: 3.199

8.  Protein kinase CK2 impact on intracellular calcium homeostasis in prostate cancer.

Authors:  Muhammad Afzal; Betsy T Kren; A Khaliq Naveed; Janeen H Trembley; Khalil Ahmed
Journal:  Mol Cell Biochem       Date:  2020-05-20       Impact factor: 3.396

9.  Targetable T-type Calcium Channels Drive Glioblastoma.

Authors:  Ying Zhang; Nichola Cruickshanks; Fang Yuan; Baomin Wang; Mary Pahuski; Julia Wulfkuhle; Isela Gallagher; Alexander F Koeppel; Sarah Hatef; Christopher Papanicolas; Jeongwu Lee; Eli E Bar; David Schiff; Stephen D Turner; Emanuel F Petricoin; Lloyd S Gray; Roger Abounader
Journal:  Cancer Res       Date:  2017-05-16       Impact factor: 12.701

10.  Calcium Channel Blocker Use and Risk of Prostate Cancer by TMPRSS2:ERG Gene Fusion Status.

Authors:  Milan S Geybels; Karen D McCloskey; Ian G Mills; Janet L Stanford
Journal:  Prostate       Date:  2016-10-18       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.